59 results
Page 2 of 3
S-3
yzs605i4uhp vkf
4 Feb 22
Shelf registration
4:36pm
8-K
EX-99.1
izvr8s5ah9k0834dc
5 Jan 22
InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook
2:22pm
8-K
EX-99.1
5huwgxrt
10 Nov 21
InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
1:08pm
8-K
EX-99.1
3kczj4enmb91dn5
3 Nov 21
Other Events
2:00pm
DEF 14A
kgag5z 7y
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
o04s29kza ycel
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
cxgpa 0m6ij99vju
24 Sep 21
Annual report
7:31am
424B3
qohhq15jf0y2pygmx
22 Jul 21
Prospectus supplement
10:27am
424B3
dkz53ve xxr
16 Mar 21
Prospectus supplement
12:00am
8-K
EX-99.1
g35j x09uzdsvj6s
20 Jan 21
Regulation FD Disclosure
3:43pm
8-K
EX-99.1
ha5mj838dkh6q6t
19 Jan 21
Regulation FD Disclosure
2:42pm
424B4
ch8jd
13 Nov 20
Prospectus supplement with pricing info
8:52pm
S-1
v1qag7
19 Jun 20
IPO registration
4:59pm
S-1
EX-10.4.2
6beqm9h
19 Jun 20
IPO registration
4:59pm